Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antibody-drug conjugates or ADCs are a class of biological drugs designed as targeted therapies for cancer treatment. Unlike chemotherapy, ADC is designed to target and kill tumor cells while preserving healthy cells.
By 2030, its compound annual growth rate (CAGR) will grow by more than 20% due to its growing popularity and therapeutic potential. ADC has six commercially available drugs, which are currently considered to be effective targeted anti-cancer therapies with potential for the treatment of many other diseases. The analysis said that the success of such products can be attributed to their ability to effectively identify and eliminate disease-related cells/pathogens, while the risk of side effects related to treatment is greatly reduced.
Antibody drug conjugates are currently considered to be effective targeted anti-cancer therapies, which will lead to market growth. The increase in the number of cancers has promoted the development of the market. The government and medical institutions have increased investment in research and development of antibody-drug conjugates, which has promoted the further expansion of the market.
This report elaborates on the current development of the Antibody-drug Conjugates industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
ImmunoGen
Takeda
Roche
Seattle Genetics
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Adcetris
Kadcyla
Application:
Breast Cancer
Lymphoma
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Antibody-drug Conjugates Industry Overview
-
1.1.1 Antibody-drug Conjugates Market Scope and Market Segments
-
1.1.2 Antibody-drug Conjugates Industry Characteristics
-
1.1.3 Global and China Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Antibody-drug Conjugates Production Value and Growth Rate (2017-2028)
-
1.2 Global Antibody-drug Conjugates Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Adcetris
-
1.2.2 Kadcyla
-
1.3 Global Antibody-drug Conjugates Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Breast Cancer
-
1.3.2 Lymphoma
-
1.4 Market Analysis by Region
-
1.4.1 North America Antibody-drug Conjugates Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Antibody-drug Conjugates Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Antibody-drug Conjugates Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Antibody-drug Conjugates Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Antibody-drug Conjugates Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Antibody-drug Conjugates Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Antibody-drug Conjugates Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Antibody-drug Conjugates Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Antibody-drug Conjugates Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Antibody-drug Conjugates Industry Porter's Five Forces Model Analysis
-
2.2.3 Antibody-drug Conjugates Industry PEST Analysis
-
2.3 Antibody-drug Conjugates Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Antibody-drug Conjugates Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Antibody-drug Conjugates Industry
Chapter 3 Global and China Antibody-drug Conjugates Market, by Manufacturer
-
3.1 Global and China Antibody-drug Conjugates Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Antibody-drug Conjugates Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Antibody-drug Conjugates Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Antibody-drug Conjugates Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Antibody-drug Conjugates Market Top 3 Players
Chapter 4 Global and China Antibody-drug Conjugates Market, by Type (2017-2028)
-
4.1 Antibody-drug Conjugates Market Trend, by Type
-
4.2 Global Antibody-drug Conjugates Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Antibody-drug Conjugates Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Antibody-drug Conjugates Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Antibody-drug Conjugates Price Trend, by Type (2017-2028)
-
4.3 China Antibody-drug Conjugates Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Antibody-drug Conjugates Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Antibody-drug Conjugates Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Antibody-drug Conjugates Price Trend, by Type (2017-2028)
Chapter 5 Global and China Antibody-drug Conjugates Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Antibody-drug Conjugates Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Antibody-drug Conjugates Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Antibody-drug Conjugates Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Antibody-drug Conjugates Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Antibody-drug Conjugates Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Antibody-drug Conjugates Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Antibody-drug Conjugates Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Antibody-drug Conjugates Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Antibody-drug Conjugates Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Antibody-drug Conjugates Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Antibody-drug Conjugates Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Antibody-drug Conjugates Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Antibody-drug Conjugates Market Analysis
-
7.1 North America Antibody-drug Conjugates Market, by Type
-
7.2 North America Antibody-drug Conjugates Market, by Application
-
7.3 North America Antibody-drug Conjugates Market Analysis and Forecast, by Country
-
7.3.1 United States Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Antibody-drug Conjugates Market Analysis
-
8.1 Europe Antibody-drug Conjugates Market, by Type
-
8.2 Europe Antibody-drug Conjugates Market, by Application
-
8.3 Europe Antibody-drug Conjugates Market Analysis and Forecast, by Country
-
8.3.1 Germany Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Antibody-drug Conjugates Market Analysis
-
9.1 APAC Antibody-drug Conjugates Market, by Type
-
9.2 APAC Antibody-drug Conjugates Market, by Application
-
9.3 APAC Antibody-drug Conjugates Market Analysis and Forecast, by Country
-
9.3.1 China Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Antibody-drug Conjugates Market Analysis
-
10.1 Latin America, Middle East and Africa Antibody-drug Conjugates Market, by Type
-
10.2 Latin America, Middle East and Africa Antibody-drug Conjugates Market, by Application
-
10.3 Latin America, Middle East and Africa Antibody-drug Conjugates Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Antibody-drug Conjugates Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Antibody-drug Conjugates Company Profiles
-
11.1 ImmunoGen
-
11.1.1 ImmunoGen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 ImmunoGen Antibody-drug Conjugates Product Profiles, Application and Specification
-
11.1.3 ImmunoGen Antibody-drug Conjugates Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Takeda
-
11.2.1 Takeda Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Takeda Antibody-drug Conjugates Product Profiles, Application and Specification
-
11.2.3 Takeda Antibody-drug Conjugates Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Roche
-
11.3.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Roche Antibody-drug Conjugates Product Profiles, Application and Specification
-
11.3.3 Roche Antibody-drug Conjugates Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Seattle Genetics
-
11.4.1 Seattle Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Seattle Genetics Antibody-drug Conjugates Product Profiles, Application and Specification
-
11.4.3 Seattle Genetics Antibody-drug Conjugates Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Antibody-drug Conjugates Industry Investment Prospect and Risk Assessment
-
12.1 Antibody-drug Conjugates Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Antibody-drug Conjugates Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure China Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure Global Antibody-drug Conjugates Production Value and Growth Rate (2017-2028)
-
Figure China Antibody-drug Conjugates Production Value and Growth Rate (2017-2028)
-
Figure Global Antibody-drug Conjugates Market Size and Growth Rate of Adcetris (2017-2028)
-
Figure Global Antibody-drug Conjugates Market Size and Growth Rate of Kadcyla (2017-2028)
-
Figure Global Antibody-drug Conjugates Market Size and Growth Rate of Breast Cancer (2017-2028)
-
Figure Global Antibody-drug Conjugates Market Size and Growth Rate of Lymphoma (2017-2028)
-
Figure North America Antibody-drug Conjugates Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Antibody-drug Conjugates Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Antibody-drug Conjugates Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Antibody-drug Conjugates Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Antibody-drug Conjugates Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Antibody-drug Conjugates Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Antibody-drug Conjugates Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Antibody-drug Conjugates Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Antibody-drug Conjugates Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Antibody-drug Conjugates Market Share, by Manufacturer in 2021
-
Figure Global and China Antibody-drug Conjugates Market Share, by Manufacturer in 2022
-
Table Global Antibody-drug Conjugates Sales Volume, by Type (2017-2028)
-
Table Global Antibody-drug Conjugates Sales Volume Share, by Type (2017-2028)
-
Figure Global Antibody-drug Conjugates Sales Volume Share, by Type (2017-2028)
-
Table Global Antibody-drug Conjugates Sales Value, by Type (2017-2028)
-
Table Global Antibody-drug Conjugates Sales Value Share, by Type (2017-2028)
-
Figure Global Antibody-drug Conjugates Price Trend, by Type (2017-2028)
-
Table China Antibody-drug Conjugates Sales Volume, by Type (2017-2028)
-
Table China Antibody-drug Conjugates Sales Volume Share, by Type (2017-2028)
-
Figure China Antibody-drug Conjugates Sales Volume Share, by Type (2017-2028)
-
Table China Antibody-drug Conjugates Sales Value, by Type (2017-2028)
-
Table China Antibody-drug Conjugates Sales Value Share, by Type (2017-2028)
-
Figure China Antibody-drug Conjugates Price Trend, by Type (2017-2028)
-
Table Global Antibody-drug Conjugates Sales Volume, by Application (2017-2028)
-
Table Global Antibody-drug Conjugates Sales Volume Share, by Application (2017-2028)
-
Figure Global Antibody-drug Conjugates Sales Volume Share, by Application (2017-2028)
-
Table Global Antibody-drug Conjugates Sales Value, by Application (2017-2028)
-
Table Global Antibody-drug Conjugates Sales Value Share, by Application (2017-2028)
-
Figure Global Antibody-drug Conjugates Sales Value Share, by Application (2017-2028)
-
Table China Antibody-drug Conjugates Sales Volume, by Application (2017-2028)
-
Table China Antibody-drug Conjugates Sales Volume Share, by Application (2017-2028)
-
Figure China Antibody-drug Conjugates Sales Volume Share, by Application (2017-2028)
-
Table China Antibody-drug Conjugates Sales Value, by Application (2017-2028)
-
Table China Antibody-drug Conjugates Sales Value Share, by Application (2017-2028)
-
Figure China Antibody-drug Conjugates Sales Value Share, by Application (2017-2028)
-
Figure China Antibody-drug Conjugates Production, Import, Consumption and Export (2017-2022)
-
Figure North America Antibody-drug Conjugates Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Antibody-drug Conjugates Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Antibody-drug Conjugates Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Antibody-drug Conjugates Production, Import, Consumption and Export (2017-2022)
-
Table North America Antibody-drug Conjugates Sales Volume, by Type (2017-2028)
-
Table North America Antibody-drug Conjugates Sales Volume Share, by Type (2017-2028)
-
Figure North America Antibody-drug Conjugates Sales Volume Share, by Type (2017-2028)
-
Table North America Antibody-drug Conjugates Sales Volume, by Application (2017-2028)
-
Table North America Antibody-drug Conjugates Sales Volume Share, by Application (2017-2028)
-
Figure North America Antibody-drug Conjugates Sales Volume Share, by Application (2017-2028)
-
Figure United States Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure United States Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure Canada Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Table Europe Antibody-drug Conjugates Sales Volume, by Type (2017-2028)
-
Table Europe Antibody-drug Conjugates Sales Volume Share, by Type (2017-2028)
-
Figure Europe Antibody-drug Conjugates Sales Volume Share, by Type (2017-2028)
-
Table Europe Antibody-drug Conjugates Sales Volume, by Application (2017-2028)
-
Table Europe Antibody-drug Conjugates Sales Volume Share, by Application (2017-2028)
-
Figure Europe Antibody-drug Conjugates Sales Volume Share, by Application (2017-2028)
-
Figure Germany Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure UK Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure UK Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure France Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure France Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure Italy Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure Spain Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure Poland Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure Russia Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Table APAC Antibody-drug Conjugates Sales Volume, by Type (2017-2028)
-
Table APAC Antibody-drug Conjugates Sales Volume Share, by Type (2017-2028)
-
Figure APAC Antibody-drug Conjugates Sales Volume Share, by Type (2017-2028)
-
Table APAC Antibody-drug Conjugates Sales Volume, by Application (2017-2028)
-
Table APAC Antibody-drug Conjugates Sales Volume Share, by Application (2017-2028)
-
Figure APAC Antibody-drug Conjugates Sales Volume Share, by Application (2017-2028)
-
Figure China Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure China Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure Japan Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure India Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure India Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Antibody-drug Conjugates Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Antibody-drug Conjugates Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Antibody-drug Conjugates Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Antibody-drug Conjugates Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Antibody-drug Conjugates Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Antibody-drug Conjugates Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Antibody-drug Conjugates Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Antibody-drug Conjugates Sales Value and Growth Rate (2017-2028)
-
Table ImmunoGen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table ImmunoGen Product Profiles, Application and Specification
-
Table ImmunoGen Antibody-drug Conjugates Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Takeda Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Takeda Product Profiles, Application and Specification
-
Table Takeda Antibody-drug Conjugates Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Roche Product Profiles, Application and Specification
-
Table Roche Antibody-drug Conjugates Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Seattle Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Seattle Genetics Product Profiles, Application and Specification
-
Table Seattle Genetics Antibody-drug Conjugates Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
